Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Vemurafenib and cobimetinib ‐ induced toxic epidermal necrolysis in a patient with metastatic melanoma (CROSBI ID 271127)

Prilog u časopisu | kratko priopćenje | međunarodna recenzija

Poduje, Sanja ; Marić Brozić, Jasmina ; Prkačin, Ivana ; Delaš Aždajić, Marija ; Goren, Andy Vemurafenib and cobimetinib ‐ induced toxic epidermal necrolysis in a patient with metastatic melanoma // Dermatologic therapy, 33 (2019), 1; e13174, 1. doi: 10.1111/dth.13174

Podaci o odgovornosti

Poduje, Sanja ; Marić Brozić, Jasmina ; Prkačin, Ivana ; Delaš Aždajić, Marija ; Goren, Andy

engleski

Vemurafenib and cobimetinib ‐ induced toxic epidermal necrolysis in a patient with metastatic melanoma

Combination therapy in the treatment of metastatic melanoma has been associated with more durable response rate compared to monotherapy. However, previous studies have shown that combined target therapy commonly causes a wide spectrum of adverse events. These adverse reactions are usually manageable, however, it is always necessary to compare drug efficacy with its potential adverse effects. Toxic epidermal necrolysis represents severe mucocutaneous reaction, usually triggered by medications and characterized by extensive necrosis and detachment of the epidermis. Here we present a first case of toxic epidermal necrolysis induced by combined target therapy (vemurafenib plus cobimetinib). The case was observed in a young patient with BRAF mutant melanoma who was started on first‐line metastatic immunotherapy with pembrolisumab.

combined target therapy ; toxic epidermal necrolysis ; metastatic melanoma

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

33 (1)

2019.

e13174

1

objavljeno

1396-0296

1529-8019

10.1111/dth.13174

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost